Coloplast A/S (CLPBY) to Release Quarterly Earnings on Tuesday

Coloplast A/S (OTCMKTS:CLPBY) is projected to release its earnings data on Tuesday, February 4th. Analysts expect Coloplast A/S to post earnings of $0.08 per share for the quarter. Coloplast A/S has set its FY 2025 guidance at EPS.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $1.02 billion during the quarter. Coloplast A/S had a return on equity of 30.19% and a net margin of 18.69%. On average, analysts expect Coloplast A/S to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Coloplast A/S Stock Up 2.0 %

Coloplast A/S stock opened at $11.66 on Tuesday. Coloplast A/S has a 52 week low of $10.63 and a 52 week high of $14.34. The business’s 50-day moving average price is $11.58 and its 200 day moving average price is $12.62. The company has a quick ratio of 0.66, a current ratio of 1.02 and a debt-to-equity ratio of 0.92.

Coloplast A/S Increases Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Monday, December 9th were issued a dividend of $0.2435 per share. This is a positive change from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date was Monday, December 9th. Coloplast A/S’s payout ratio is 93.94%.

Analyst Upgrades and Downgrades

Several research firms recently commented on CLPBY. Hsbc Global Res upgraded shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research report on Monday, November 18th. UBS Group upgraded Coloplast A/S from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 11th.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.